Professor of Surgery and of Otolaryngology/Head and Neck Surgery, Temple University
General Surgery
Dr. John A. Ridge, MD
|
|
Give Review
John A. Ridge practices General Surgery. He graduated from Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He over the years received 7 awards: "Philadelphia Magazine", "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Director's Commendation", "Super Doctor" and "Fellow (FACS)". Dr. John A. Ridge is also a published MD. He has 62 paper published. The most recent paper is: ACR Appropriateness Criteria() Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Doctor John A. Ridge, MD accepts all Medicare patients.
Publications
- ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
- Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal Cancer.
- Current Status of Clinical Trials in Head and Neck Cancer 2014.
- p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell Carcinomas of unknown primary.
- Thyroid Carcinoma, version 2.2014.
- Increasing time to treatment initiation for head and neck Cancer: An analysis of the National Cancer Database.
- Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative On...
- Coupling of Prostate and Thyroid Cancer Diagnoses in the United States.
- Randomized Trial of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord (RTOG 9512).
- Recommended patient-reported core set of symptoms to measure in head and neck Cancer treatment trials.
- InDuction cetuximab, paclitaxel and carboplatin followed by chemoradiation with cetuximab, paclitaxel and carboplatin for stage III/IV head and neck squamous cancer: A...
- ACR Appropriateness Criteria® thyroid Carcinoma.
- Baseline health perceptions, dysphagia, and survival in patients with head and neck Cancer.
- Quantification of excision repair cross complementing group 1 (ERCC1) and survival in p16-negative squamous cell head and neck Cancers.
- Dysplasia at the margin? Investigating the case for subsequent therapy in 'Low-Risk' squamous cell Carcinoma of the oral tongue.
- Head and Neck Cancers, Version 2.2013.
- A pilot study of psychosocial functioning and vascular endothelial growth factor in head and neck Cancer patients.
- ACR Appropriateness Criteria(®) Treatment of Stage 1 T1 Glottic Cancer.
- Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx Cancer.
- Reply, Contralateral irradiation for T(limited) N2bM0 lateralized tonsil Cancer.
- Extranodal extension of Metastatic Papillary Thyroid Carcinoma: Correlation with biochemical endpoints, nodal persistence and systemic disease progression.
- Transoral resection of pharyngeal Cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7...
- Informational Needs of Head and Neck Cancer Patients.
- Psychological functioning of caregivers for head and neck Cancer patients.
- Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal Cancer: the Fox Chase Cancer Center experience.
- Head and neck Cancers.
- Improvement of the radial forearm flap donor defect by prelamination with human acellular dermal matrix.
- ACR Appropriateness Criteria(®) Retreatment of Recurrent Head and Neck Cancer After Prior Definitive Radiation Expert Panel on Radiation Oncology-Head and N...
- Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of Head-a...
- Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.
- We show pictures, they show curves.
- Surgery in the multimodality treatment of sinonasal Malignancies.
- ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell Carcinomas.
- Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell Carcinomas: results of a prospective multi-institutional trial.
- Impact of neck dissection on long-term feeding tube dependence in patients with head and neck Cancer treated with primary radiation or chemoradiation.
- The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins.
- Head and neck squamous cell Cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, ...
- Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk Head and neck squamous cell ...
- Comparison of clinical and pathological staging in head and neck squamous cell Carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.
- Postradiotherapy neck dissection for head and neck squamous cell Carcinoma: pattern of pathologic residual Carcinoma and prognosis.
- The role of Neck dissection in the combined modality therapy setting.
- Treatment of head and neck Cancer.
- Improved survival of patients with human papillomavirus-positive head and neck squamous cell Carcinoma in a prospective clinical trial.
- TP53 mutations and survival in squamous-cell Carcinoma of the head and neck.
- Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous Head and neck malignancies.
- Intensity-modulated radiotherapy for early larynx Cancer: is there a role?
- Using stereolithographic models to plan mandibular reconstruction for advanced oral cavity Cancer.
- Phase I trial of concurrent hyperfractionated split course radiOtherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, o...
- InDuction chemotherapy for larynx preservation: patient selection or therapeutic effect?
- A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among Cancer patients.
- Toxicity and outcome analysis of patients with recurrent head and neck Cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and pa...
- Methemoglobinemia: early intraoperative detection by clinical observation.
- Comparing Cancer patients who enroll in a smoking cessation program at a comprehensive Cancer center with those who decline enrollment.
- Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal Cancer.
- Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.
- Longitudinal predictors of continued tobacco use among patients diagnosed with Cancer.
- Tumor above the spinal accessory nerve in papillary thyroid Cancer that involves lateral neck nodes: a common occurrence.
- Processes of change related to smoking behavior among Cancer patients.
- Head and neck sarcomas: a comprehensive Cancer center experience.
- Metastatic cervical Carcinoma from an unknown primary: Literature review.
- Bilateral granulosa cell Tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.
Schools
Stanford University School Of Medicine
University Of Colorado
Memorial Sloan Kettering Cancer Center
Procedures Preformed
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Embolectomy, Thrombectomy, or Vessel Exploration
- Excision of Esophageal Lesion
- Excision of Parotid, Sublingual, or Submandibular Gland
- View All
Conditions Treated
- Bile Duct Cancer
- Breast Cancer
- Carcinoma in Situ
- Colorectal Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Director's Commendation
- Super Doctor
- Fellow (FACS)
Education
-
Memorial Sloan-Kettering Cancer Center -
University of Colorado -
Stanford University School of Medicine
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Drug Facts
| NPI NUMBER | 1841212008 | |
| NPPES Provider LastName | RIDGE | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 191112434 | |
| NPPES Provider State | PA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 26.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841212008 |
| Last Name Of The Provider | RIDGE |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Eric B. Unger, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Esther Han, MD |
|
|
Dr. Taqi T. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smit Singla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sagar S. Kadakia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam P. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupama S. Sharma, MD |
|
|
Dr. John Levin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abraham Shaked, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sameer A. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edgardo S. Salcedo Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pinckney J. Maxwell, MD
This Doctor is OpenDoctor Recommended.
|